Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced Ototoxicity

NCT04226456 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped poor recruitment

Conditions

Ototoxic Hearing Loss
Ototoxic Hearing Loss, Bilateral
Ototoxicity
Tinnitus

Interventions

DRUG: N-acetyl cysteine

Sponsor

Centre Hospitalier Universitaire Saint Pierre